Obesity, Childhood
Conditions
Brief summary
Evidence shows that omega-3 fatty acids lower blood triglyceride levels, lower blood pressure, enhance insulin sensitivity, and improve heart rate variability (HRV) measures, all of which may be indicators of cardiovascular health.As a result, omega-3 fatty acid supplementation may be a low-cost strategy with little adverse effects for obese youngsters, perhaps delaying the development of chronic cardiovascular illnesses.
Detailed description
This is a two-armed study , the interventional group will be given omega 3 and the control group will be given a placebo and both will be examined for the heart rate variability
Interventions
The control group will be given placebo for 3 months
The interventional group will be given omega 3 for 3 months
Sponsors
Study design
Eligibility
Inclusion criteria
* Children (5-12 years) whose parents or caregivers will agree to be enrolled in the study * Obese Children (Simple obesity ) * Both males and females
Exclusion criteria
* Patients are known to have cardiac disease * Patients with associated chronic systemic illness * Patients with 2ry obesity : (endocrine /metabolic/genetics/drug intake) * Patients on medications affecting heart rate :structural or arrhythmic
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The effect of omega-3 on heart rate variability that is represented in the root mean square of successive differences of the heart rates ( RMSSD ) in obese children | 3 months | Obese children will be examined for the effect of Omega-3 supplementation on heat rate variability |
Countries
Egypt